Addition of HER2 and CD44 to (18)F-FDG PET–based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer

OBJECTIVES: To assess the complementary value of human epidermal growth factor receptor 2 (HER2)-related biological tumor markers to clinico-radiomic models in predicting complete response to neoadjuvant chemoradiotherapy (NCRT) in esophageal cancer patients. METHODS: Expression of HER2 was assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Beukinga, Roelof J., Wang, Da, Karrenbeld, Arend, Dijksterhuis, Willemieke P. M., Faber, Hette, Burgerhof, Johannes G. M., Mul, Véronique E. M., Slart, Riemer H. J. A., Coppes, Robert P., Plukker, John Th. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Gastrointestinal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043921/
https://www.ncbi.nlm.nih.gov/pubmed/33151397
http://dx.doi.org/10.1007/s00330-020-07439-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043921/
https://www.ncbi.nlm.nih.gov/pubmed/33151397
http://dx.doi.org/10.1007/s00330-020-07439-8

Ejemplares similares